Atlas Trials

Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS

Clinical trial NCT04359290 · COMPLETED

Trial details

NCT number
NCT04359290
Sponsor
Philipps University Marburg
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
ARDS, HumanCOVID
Start date
2020-07-01
Primary completion
2020-12-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.